Home > Volumes and issues > Advances in Radiomics to Assess Immunotherapy Associated with Efficacy and Adverse Events for Non-small Cell Lung Cancer
1180 views 981 downloads
Review Articie 28 September 2023
Advances in Radiomics to Assess Immunotherapy Associated with Efficacy and Adverse Events for Non-small Cell Lung Cancer
Haoyu An 1 ,  Zhiheng Qiu 2 ,  Yukun Zhou 3 show author's information
DOI: 10.55578/joaims.230918.001
Keywords: Health informatics; Artificial intelligence; Healthcare data; Machine learning; Deep learning; Health information systems; Patient care; Systematic review
Cite this article: An H, Qiu Z, Zhou Y (2023) Advances in Radiomics to Assess Immunotherapy Associated with Efficacy and Adverse Events for Non-small Cell Lung Cancer. Journal of Artificial Intelligence for Medical Sciences, 4(2), 47-52, 2023.
Full Text PDF
Download Citation